Physician profile
Ali Tabrizchi
NPI 1710047709
$65,826.04
in general payments reported to CMS, 2019-2025
30 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $55K · 2020: $9,077 · 2021: $1,249 · 2022: $545 · 2023: $152.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $152.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $152.03 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $44,344.79 | 2019-2021 | |
| Amarin Pharma, INC. | $9,046.39 | 2019-2022 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $5,173.32 | 2019-2023 | Lifevest |
| Chiesi USA, INC. | $3,140.06 | 2019 | |
| Novartis Pharmaceuticals Corporation | $659.08 | 2019-2023 | |
| Pfizer INC. | $630.33 | 2019-2023 | |
| Amgen INC. | $501.60 | 2019-2022 | |
| Abbott Laboratories | $248.08 | 2019 | |
| Gilead Sciences, INC. | $247.00 | 2019 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $216.91 | 2019-2022 | |
| Astellas Pharma US INC | $211.72 | 2019 | |
| Astrazeneca Pharmaceuticals Lp | $211.70 | 2019-2022 | |
| Boston Scientific Corporation | $199.36 | 2019-2022 | |
| Arbor Pharmaceuticals, INC. | $148.48 | 2019-2021 | |
| Sanofi-Aventis U.S. LLC | $125.46 | 2019-2022 |
Show all 30 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $113.90 | 2021-2022 | |
| Medtronic Vascular, INC. | $81.04 | 2019-2020 | |
| Irhythm Technologies, INC. | $79.86 | 2019-2021 | |
| Kowa Pharmaceuticals America, INC. | $61.93 | 2019-2021 | |
| Cardiovascular Systems INC. | $56.34 | 2019 | |
| Daiichi Sankyo INC. | $48.00 | 2019 | |
| Bayer Healthcare Pharmaceuticals INC. | $47.74 | 2019-2020 | |
| Medicomp INC | $46.32 | 2019 | |
| Preventice Services, LLC | $38.41 | 2019 | |
| Philips North America LLC | $37.34 | 2022 | |
| Regeneron Healthcare Solutions, INC. | $29.20 | 2019 | |
| Lundbeck LLC | $28.02 | 2020 | |
| Biotronik INC. | $26.63 | 2019 | |
| Infobionic, INC | $13.64 | 2020 | |
| E.R. Squibb & Sons, L.L.C. | $13.39 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ali Tabrizchi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.